Invention Grant
- Patent Title: Bicyclic compound as a caspase inhibitor
-
Application No.: US16479673Application Date: 2018-01-23
-
Publication No.: US11434212B2Publication Date: 2022-09-06
- Inventor: Jianfeng Mou , Songliang Wu , Haiying He , Fengying Guo , Chuan Wang , Jie Li , Jian Li , Shuhui Chen
- Applicant: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
- Applicant Address: CN Lianyungang
- Assignee: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
- Current Assignee: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
- Current Assignee Address: CN Lianyungang
- Agency: Nixon Peabody LLP
- Priority: CN201710059063.8 20170123
- International Application: PCT/CN2018/073721 WO 20180123
- International Announcement: WO2018/133870 WO 20180726
- Main IPC: C07D261/18
- IPC: C07D261/18 ; C07D231/14 ; C07D233/90 ; C07D263/34 ; C07D271/06 ; C07D277/56
Abstract:
A compound represented by formula (I), a pharmaceutically acceptable salt or tautomer thereof, and an application of the compound as a caspase inhibitor.
Public/Granted literature
- US20210332019A1 Bicyclic Compound as a Caspase Inhibitor Public/Granted day:2021-10-28
Information query
